On July 3rd, 2020, Photanol BV and RENOLIT Healthcare formed a strategic partnership to develop polymers by using CO2 absorbed from the air in a direct, fully circular and CO2-neutral conversion process without the usage of (fossil) oil and gas.
We have combined our untiring passion and unbridled will to make this new future possible. The crux of the matter: classic bioplastics have significant performance challenges and/or do not decompose (entirely) after use. This is why we have set out to provide our Healthcare customers with a fully circular packaging solution for products that can be burned at the end of the life cycle, as required by regulation, without increasing the air’s CO2 content. We can only achieve this goal if the film’s polymers are made of carbon that is made from a renewable carbon source. Only by absorbing the carbon from the air, converting it into monomers, and then polymerizing it in drop-in solutions can we make a long-term contribution to curbing global warming.
For the consistent implementation of this innovative idea, we work hand in hand as partners. At RENOLIT Healthcare, for example, we are actively involved in the development of a high-performance and cost-efficient photo-bioreactor, which will be a crucial element in the scale-up of this technology.
The partnership brings a long series of benefits to our Healthcare customers and patients, including fully sustainable raw materials, a better quality of medical devices due to higher degree of purity of the raw materials, and a secured supply chain.
We are currently in the process of making our current solution scalable. The goal is that non-fossil carbon-based ethylene and propylene monomers can be offered to a wide array of users at a competitive price – a big step towards a more livable future.
Change is created together. Together Towards Health.
Further information:
https://renolit.com/healthcare
https://photanol.com